TheU.S. FDA has permitted Rybelsus (semaglutide), the primary and solely glucagon-like peptide-1 (GLP-1) analog in a capsule. “GLP-1 receptor agonists are effective medications for people with type 2 diabetes but have been underutilized in part because they have, until now, only been...